Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis
Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in H...
Saved in:
Published in: | Multiple sclerosis Vol. 14; no. 9; pp. 1175 - 1180 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London, England
SAGE Publications
01-11-2008
Sage Publications Sage Publications Ltd |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background
The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS.
Objective
To assess whether variation in HERV-K18 Env is a risk factor for MS.
Methods
We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls.
Results
Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1–6.4).
Conclusion
Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. |
---|---|
AbstractList | Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk ( chi super(2) P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P=0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1–6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. To assess whether variation in human endogenous retrovirus (HERV)-K18 env , an Epstein-Barr virus (EBV) associated superantigen, is a risk factor for multiple sclerosis (MS), we developed a SNP-based genotyping method to determine the allelic and genotypic distribution of the three alleles of HERV-K18 env. We conducted a nested case-control study amongst 207 MS cases and 403 matched controls drawn from two large ongoing cohorts, the Nurses Health Study and Nurses Health Study 2 (NHS/NHS2). Analyses were replicated in an independent series of 909 MS cases and 339 controls. Overall, in the NHS/NHS2 there was a significant association between HERV K18 env genotype and risk of MS (χ 2 p-value=0.03). As compared with individuals homozygous for the K18.2 allele, risk of MS three fold higher among carriers of two K18.3 alleles (p=0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, homozygous carriers of the K18.3 allele had a significantly increased risk of MS (RR comparing K18.3/K18.3 versus K18.2/K18.2 = 2.7; 95% CI: 1.1 to 6.4). These results suggest that variation in EBV-associated superantigen HERV-K18 env could influence the genetic susceptibility to MS. BackgroundThe human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS.ObjectiveTo assess whether variation in HERV-K18 Env is a risk factor for MS.MethodsWe developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env. We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls.ResultsOverall, there was a significant association between HERV-K18 env genotype and MS risk (chi2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4).ConclusionVariation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the etiology of multiple sclerosis (MS), HERV-K18 Env is a plausible candidate for association with MS. Objective To assess whether variation in HERV-K18 Env is a risk factor for MS. Methods We developed a single nucleotide polymorphism-based genotyping method to determine the distribution of the three alleles of HERV-K18 env . We then conducted a nested case-control study including 207 MS cases and 403 matched controls. Analyses were replicated in an independent series of 909 MS cases and 339 controls. Results Overall, there was a significant association between HERV-K18 env genotype and MS risk (χ2 P = 0.03). As compared with K18.2/K18.2 individuals, risk of MS was three fold higher among K18.3/K18.3 individuals (P = 0.03). An increase in MS risk among carriers of the K18.3 allele was also observed in the replication study, but did not reach statistical significance. In pooled analyses, K18.3/K18.3 individuals had a significantly increased risk of MS (relative risks [RR] comparing K18.3/K18.3 vs K18.2/K18.2 = 2.7; 95% confidence interval: 1.1-6.4). Conclusion Variation in EBV-associated superantigen HERV-K18 Env could influence the genetic susceptibility to MS. [PUBLICATION ABSTRACT] |
Author | Alroy, KA Munger, KL Tai, AK Huber, BT Ascherio, A O’Reilly, EJ Simon, KC |
AuthorAffiliation | 2 Department of Nutrition, Harvard School of Public Health, Boston, MA, USA 1 Department of Pathology, Tufts University School of Medicine, Boston, MA, USA 3 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA 4 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA |
AuthorAffiliation_xml | – name: 3 Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA – name: 1 Department of Pathology, Tufts University School of Medicine, Boston, MA, USA – name: 2 Department of Nutrition, Harvard School of Public Health, Boston, MA, USA – name: 4 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA |
Author_xml | – sequence: 1 givenname: AK surname: Tai fullname: Tai, AK organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA – sequence: 2 givenname: EJ surname: O’Reilly fullname: O’Reilly, EJ organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA – sequence: 3 givenname: KA surname: Alroy fullname: Alroy, KA organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA – sequence: 4 givenname: KC surname: Simon fullname: Simon, KC organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA – sequence: 5 givenname: KL surname: Munger fullname: Munger, KL organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA – sequence: 6 givenname: BT surname: Huber fullname: Huber, BT organization: Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, USA – sequence: 7 givenname: A surname: Ascherio fullname: Ascherio, A organization: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA; Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, Massachusetts, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20876759$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18701576$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1rHSEUxaUkNB_tvqsihWY3qTrqdTaFENKkaaCb7MVR59V0Rl915kH_-_p4j6QNlKwUzu8er-ecoIOYokfoHSXnlAJ8oq1gXChBFOm45PQVOqYcoCEdkIN6r3Kz1Y_QSSkPhBCAVrxGR1QBoQLkMbq9WSYTsY8urXxMS8HZzzltQl5K840qfBU32BRscA7lJx6MnVPGIeJpGeewHj0udvQ5lVDeoMPBjMW_3Z-n6P7L1f3lTXP3_frr5cVdY4WSc0OdcEBAsMErbrmVLedAmJNMDM5ax50zru1sx7u-7Qn0nPW9Mr0F1XtJ21P0eWe7XvrJO-vjnM2o1zlMJv_WyQT9rxLDD71KG81AcAqiGpztDXL6tfgy6ykU68fRRF8D0LID2lJQL4K0Ux0HTir44Rn4kJYcawiaUaW4FGwLkR1ka1ol--FxZUr0tk39vM068v7vrz4N7OurwMc9YIo145BNtKE8cowokCC6yjU7rpiVf1ruvw__ARivtg8 |
CODEN | MUSCFZ |
CitedBy_id | crossref_primary_10_1128_jvi_00356_22 crossref_primary_10_3390_ijms23158330 crossref_primary_10_1371_journal_pone_0053623 crossref_primary_10_1177_1352458511416487 crossref_primary_10_1007_s00415_009_5068_8 crossref_primary_10_1007_s00109_021_02080_4 crossref_primary_10_3109_08830185_2010_485333 crossref_primary_10_1002_cti2_1451 crossref_primary_10_1016_j_jcv_2009_05_015 crossref_primary_10_3109_03009742_2013_779021 crossref_primary_10_3390_ijms21217855 crossref_primary_10_1016_j_envres_2015_11_017 crossref_primary_10_1111_j_1365_2249_2010_04121_x crossref_primary_10_1111_ane_12775 crossref_primary_10_1016_j_jcv_2009_05_019 crossref_primary_10_3390_ph14010070 crossref_primary_10_1007_s11910_009_0059_9 crossref_primary_10_1007_s11033_016_4004_0 crossref_primary_10_1016_j_jneuroim_2017_02_017 crossref_primary_10_1016_j_it_2009_03_007 crossref_primary_10_1111_j_1365_2249_2010_04132_x crossref_primary_10_1007_s11910_014_0488_y crossref_primary_10_1371_journal_pone_0172415 crossref_primary_10_1155_2024_2313062 crossref_primary_10_1017_S2040174411000353 crossref_primary_10_1186_s12985_017_0719_3 crossref_primary_10_1016_j_neurol_2009_07_004 crossref_primary_10_1371_journal_pone_0062090 crossref_primary_10_1016_j_jneuroim_2021_577636 crossref_primary_10_1007_s11481_010_9201_3 crossref_primary_10_3389_fviro_2022_972156 crossref_primary_10_1111_j_1872_034X_2009_00605_x crossref_primary_10_3390_ijms22115738 crossref_primary_10_3109_08830185_2013_823422 crossref_primary_10_1016_j_bbadis_2010_06_012 crossref_primary_10_3389_fmicb_2020_01690 crossref_primary_10_3390_genes14122150 crossref_primary_10_1007_s10571_014_0100_7 crossref_primary_10_1016_j_jns_2016_11_060 crossref_primary_10_3389_fmicb_2018_00265 crossref_primary_10_3390_genes15060745 crossref_primary_10_1038_nri2527 crossref_primary_10_3390_ijms130911718 crossref_primary_10_1016_j_msard_2021_103318 crossref_primary_10_1189_jlb_0709517 crossref_primary_10_1016_j_bbadis_2010_07_016 crossref_primary_10_1128_JVI_01507_17 crossref_primary_10_3390_v4123701 crossref_primary_10_1186_1743_422X_10_172 |
Cites_doi | 10.1038/ng1885 10.1007/s100720170011 10.1016/S0140-6736(81)91527-0 10.1084/jem.184.3.971 10.1002/ana.21117 10.1212/WNL.53.8.1711 10.3109/13550289609146888 10.1002/ana.20820 10.1001/jama.293.20.2496 10.1016/S1074-7613(01)00212-6 10.1056/NEJMoa073493 10.1128/JVI.69.2.871-881.1995 10.1212/WNL.55.2.164 10.1093/brain/awl067 10.1084/jem.20071030 10.2337/diabetes.53.3.852 10.1016/S0092-8674(00)80338-4 10.1016/S0022-510X(99)00298-1 10.1097/00001648-200003000-00023 10.1136/jnnp.57.8.975 10.1093/oxfordjournals.aje.a009878 10.1038/ni835 10.1056/NEJM200102013440502 10.1128/9781555815844.ch4 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS SAGE Publications © Nov 2008 |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: SAGE Publications © Nov 2008 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7T5 7TK 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH H94 K9- K9. M0R M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1177/1352458508094641 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Consumer Health Database ProQuest Health & Medical Complete (Alumni) Family Health Database (Proquest) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts ProQuest Central Essentials ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Family Health (Alumni Edition) Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) AIDS and Cancer Research Abstracts Immunology Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1477-0970 |
EndPage | 1180 |
ExternalDocumentID | 1588835541 10_1177_1352458508094641 18701576 20876759 10.1177_1352458508094641 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: R01 NS047467-04 – fundername: NINDS NIH HHS grantid: R01 NS047467 – fundername: PHS HHS grantid: R01N504767 |
GroupedDBID | --- -MK -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 3V. 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADTT AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AAMGE AANSI AAPEO AAQDB AAQXH AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACSBE ACSIQ ACTQU ACUAV ACUIR ACXKE ACXMB ADBBV ADEIA ADMPF ADNBR ADRRZ ADTBJ ADUCT ADUKL ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEUIJ AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFUIA AGKLV AGNHF AGWFA AHHFK AHMBA AIGRN AIOMO AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALJHS ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS EJD EMOBN ESX F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION HF~ HMCUK HVGLF HZ~ J8X JCYGO K.F K.J K9- M0R M1P M4V N9A O9- P.B P2P PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH AAGHA AAICN AAMXZ AANGY AAPBV AAWVI ABJOC ABNLC ABPTK ADGDL AEMII AERUW AGHDM AGTGN AIFIH AUVAJ BFDSU H13 IQODW P.9 ZA5 ACJER AFVCE AGWNL AJXGE ALKWR CGR CUY CVF ECM EIF NPM AAYXX ADVBO CITATION 7T5 7TK 7U9 7XB 8FK H94 K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c586t-1d5d70752fe84c4c6344702d625fdccd4ddad39c949b3b07b42bb8abc78be613 |
IEDL.DBID | ARPSY |
ISSN | 1352-4585 |
IngestDate | Tue Sep 17 21:17:54 EDT 2024 Fri Oct 25 01:17:14 EDT 2024 Fri Oct 25 02:47:33 EDT 2024 Tue Nov 19 07:12:09 EST 2024 Fri Nov 22 02:13:56 EST 2024 Tue Oct 15 23:35:07 EDT 2024 Sun Oct 22 16:04:59 EDT 2023 Tue Jul 16 20:43:19 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | endogenous retroviruses HLA polymorphisms multiple sclerosis HERV-K18 Human HLA-System Nervous system diseases Multiple sclerosis Inflammatory disease Central nervous system disease Risk factor Degenerative disease Polymorphism |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c586t-1d5d70752fe84c4c6344702d625fdccd4ddad39c949b3b07b42bb8abc78be613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc2754175?pdf=render |
PMID | 18701576 |
PQID | 218846520 |
PQPubID | 38324 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2754175 proquest_miscellaneous_69713178 proquest_miscellaneous_19894740 proquest_journals_218846520 crossref_primary_10_1177_1352458508094641 pubmed_primary_18701576 pascalfrancis_primary_20876759 sage_journals_10_1177_1352458508094641 |
PublicationCentury | 2000 |
PublicationDate | 2008-11-01 |
PublicationDateYYYYMMDD | 2008-11-01 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: London – name: England |
PublicationTitle | Multiple sclerosis |
PublicationTitleAlternate | Mult Scler |
PublicationYear | 2008 |
Publisher | SAGE Publications Sage Publications Sage Publications Ltd |
Publisher_xml | – name: SAGE Publications – name: Sage Publications – name: Sage Publications Ltd |
References | Rosati G 2001; 22 Conrad B, Weissmahr RN, Böni J, Arcari R, Schüpbach J, Mach B 1997; 90 Hernán MA, Olek MJ, Ascherio A 1999; 53 Warner HB, Carp RI 1981; 2 Levin LI, Munger KL, Rubertone MV 2005; 293 Klaman LD, Thorley-Lawson DA 1995; 69 Rand KH, Houck H, Denslow ND, Heilman KM 2000; 173 Hunter SF, Hafler DA 2000; 55 Lunemann JD, Edwards N, Muraro PA 2006; 129 Ascherio A, Munch M 2000; 11 Sutkowski N, Palkama T, Ciurli C, Sekaly R-P, Thorley-Lawson DA, Huber BT 1996; 184 Sanders VJ, Felisan S, Waddell A, Tourtellotte WW 1996; 2 Ascherio A, Zhang SM, Hernan MA 2001; 344 Ascherio A, Munger KL 2007; 61 Serafini B, Rosicarelli B, Franciotta D 2007; 204 Marguerat S, Wang WY, Todd JA, Conrad B 2004; 53 de Bakker PIW, McVean G, Sabeti PC 2006; 38 Schaid DJ, Jacobsen SJ 1999; 149 Stauffer Y, Marguerat S, Meylan F 2001; 15 The International Multiple Sclerosis Genetics Consortium 2007; 357 Lang HL, Jacobsen H, Ikemizu S 2002; 3 Thacker EL, Mirzaei F, Ascherio A 2006; 59 Hilton DA, Love S, Fletcher A, Pringle JH 1994; 57 9064357 - J Exp Med. 1996 Sep 1;184(3):971-80 14988274 - Diabetes. 2004 Mar;53(3):852-4 11021623 - Epidemiology. 2000 Mar;11(2):220-4 11172163 - N Engl J Med. 2001 Feb 1;344(5):327-32 11603614 - Neurol Sci. 2001 Apr;22(2):117-39 11672541 - Immunity. 2001 Oct;15(4):591-601 17984305 - J Exp Med. 2007 Nov 26;204(12):2899-912 10675577 - J Neurol Sci. 2000 Feb 1;173(1):32-9 12244309 - Nat Immunol. 2002 Oct;3(10):940-3 16569670 - Brain. 2006 Jun;129(Pt 6):1493-506 16502434 - Ann Neurol. 2006 Mar;59(3):499-503 6118702 - Lancet. 1981 Dec 5;2(8258):1290 16998491 - Nat Genet. 2006 Oct;38(10):1166-72 17444504 - Ann Neurol. 2007 Apr;61(4):288-99 9244304 - Cell. 1997 Jul 25;90(2):303-13 10206619 - Am J Epidemiol. 1999 Apr 15;149(8):706-11 7815555 - J Virol. 1995 Feb;69(2):871-81 10563617 - Neurology. 1999 Nov 10;53(8):1711-8 10908883 - Neurology. 2000 Jul 25;55(2):164-5 15914750 - JAMA. 2005 May 25;293(20):2496-500 17660530 - N Engl J Med. 2007 Aug 30;357(9):851-62 atypb9 atypb8 atypb19 atypb15 atypb16 atypb17 atypb18 atypb11 atypb22 atypb12 atypb23 atypb13 atypb24 atypb14 atypb1 atypb3 atypb20 atypb2 atypb10 atypb21 atypb5 atypb4 atypb7 atypb6 |
References_xml | – volume: 357 start-page: 851 year: 2007 end-page: 862 article-title: Risk alleles for multiple sclerosis identified by a genomewide study publication-title: N Engl J Med contributor: fullname: The International Multiple Sclerosis Genetics Consortium – volume: 38 start-page: 1166 year: 2006 end-page: 1172 article-title: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC publication-title: Nat Genet contributor: fullname: Sabeti PC – volume: 59 start-page: 499 year: 2006 end-page: 503 article-title: Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis publication-title: Ann Neurol contributor: fullname: Ascherio A – volume: 57 start-page: 975 year: 1994 end-page: 976 article-title: Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation publication-title: J Neurol Neurosurg Psychiatry contributor: fullname: Pringle JH – volume: 204 start-page: 2899 year: 2007 end-page: 2912 article-title: Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain publication-title: J Exp Med contributor: fullname: Franciotta D – volume: 3 start-page: 940 year: 2002 end-page: 943 article-title: A functional and structural basis for TCR cross-reactivity in multiple sclerosis publication-title: Nat Immunol contributor: fullname: Ikemizu S – volume: 69 start-page: 871 year: 1995 end-page: 881 article-title: Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site publication-title: J Virol contributor: fullname: Thorley-Lawson DA – volume: 344 start-page: 327 year: 2001 end-page: 332 article-title: Hepatitis B vaccination and the risk of multiple sclerosis publication-title: N Engl J Med contributor: fullname: Hernan MA – volume: 22 start-page: 117 year: 2001 end-page: 139 article-title: The prevalence of multiple sclerosis in the world: an update publication-title: Neurol Sci contributor: fullname: Rosati G – volume: 2 start-page: 1290 year: 1981 article-title: Multiple sclerosis and Epstein-Barr virus publication-title: Lancet contributor: fullname: Carp RI – volume: 149 start-page: 706 year: 1999 end-page: 711 article-title: Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions publication-title: Am J Epidemiol contributor: fullname: Jacobsen SJ – volume: 173 start-page: 32 year: 2000 end-page: 39 article-title: Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis publication-title: J Neurol Sci contributor: fullname: Heilman KM – volume: 184 start-page: 971 year: 1996 end-page: 980 article-title: An Epstein-Barr virus-associated superantigen publication-title: J Exp Med contributor: fullname: Huber BT – volume: 53 start-page: 1711 year: 1999 end-page: 1718 article-title: Geographic variation of MS incidence in two prospective studies of US women publication-title: Neurology contributor: fullname: Ascherio A – volume: 90 start-page: 303 year: 1997 end-page: 313 article-title: A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes publication-title: Cell contributor: fullname: Mach B – volume: 53 start-page: 852 year: 2004 end-page: 854 article-title: Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes publication-title: Diabetes contributor: fullname: Conrad B – volume: 2 start-page: 249 year: 1996 end-page: 258 article-title: Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction publication-title: J Neurovirol contributor: fullname: Tourtellotte WW – volume: 55 start-page: 164 year: 2000 end-page: 165 article-title: Ubiquitous pathogens: links between infection and autoimmunity in MS publication-title: Neurology contributor: fullname: Hafler DA – volume: 15 start-page: 591 year: 2001 end-page: 601 article-title: Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity publication-title: Immunity contributor: fullname: Meylan F – volume: 11 start-page: 220 year: 2000 end-page: 224 article-title: Epstein-Barr virus and multiple sclerosis publication-title: Epidemiology contributor: fullname: Munch M – volume: 293 start-page: 2496 year: 2005 end-page: 2500 article-title: Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis publication-title: JAMA contributor: fullname: Rubertone MV – volume: 61 start-page: 288 year: 2007 end-page: 299 article-title: Environmental risk factors for multiple sclerosis. Part I: the role of infection publication-title: Ann Neurol contributor: fullname: Munger KL – volume: 129 start-page: 1493 year: 2006 end-page: 1506 article-title: Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis publication-title: Brain contributor: fullname: Muraro PA – ident: atypb13 doi: 10.1038/ng1885 – ident: atypb1 doi: 10.1007/s100720170011 – ident: atypb3 doi: 10.1016/S0140-6736(81)91527-0 – ident: atypb21 doi: 10.1084/jem.184.3.971 – ident: atypb5 doi: 10.1002/ana.21117 – ident: atypb10 doi: 10.1212/WNL.53.8.1711 – ident: atypb16 doi: 10.3109/13550289609146888 – ident: atypb6 doi: 10.1002/ana.20820 – ident: atypb7 doi: 10.1001/jama.293.20.2496 – ident: atypb9 doi: 10.1016/S1074-7613(01)00212-6 – ident: atypb11 doi: 10.1056/NEJMoa073493 – ident: atypb22 doi: 10.1128/JVI.69.2.871-881.1995 – ident: atypb2 doi: 10.1212/WNL.55.2.164 – ident: atypb20 doi: 10.1093/brain/awl067 – ident: atypb17 doi: 10.1084/jem.20071030 – ident: atypb23 doi: 10.2337/diabetes.53.3.852 – ident: atypb8 doi: 10.1016/S0092-8674(00)80338-4 – ident: atypb18 doi: 10.1016/S0022-510X(99)00298-1 – ident: atypb4 doi: 10.1097/00001648-200003000-00023 – ident: atypb15 doi: 10.1136/jnnp.57.8.975 – ident: atypb14 doi: 10.1093/oxfordjournals.aje.a009878 – ident: atypb19 doi: 10.1038/ni835 – ident: atypb12 doi: 10.1056/NEJM200102013440502 – ident: atypb24 doi: 10.1128/9781555815844.ch4 |
SSID | ssj0007735 |
Score | 2.1971886 |
Snippet | Background
The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the... BackgroundThe human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the... Background The human endogenous retrovirus (HERV)-K18 Env is an Epstein-Barr virus (EBV)-associated superantigen. Given the evidence for a role of EBV in the... To assess whether variation in human endogenous retrovirus (HERV)-K18 env , an Epstein-Barr virus (EBV) associated superantigen, is a risk factor for multiple... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis sage |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1175 |
SubjectTerms | Biological and medical sciences Case-Control Studies Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Endogenous Retroviruses - genetics Epstein-Barr virus Genetic Predisposition to Disease - epidemiology Genotype Human endogenous retrovirus Humans Medical sciences Membrane Proteins - genetics Membrane Proteins - immunology Multiple Sclerosis - epidemiology Multiple Sclerosis - immunology Multiple Sclerosis - virology Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Polymorphism, Single Nucleotide Risk Factors Superantigens - genetics Superantigens - immunology |
Title | Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis |
URI | https://journals.sagepub.com/doi/full/10.1177/1352458508094641 https://www.ncbi.nlm.nih.gov/pubmed/18701576 https://www.proquest.com/docview/218846520 https://search.proquest.com/docview/19894740 https://search.proquest.com/docview/69713178 https://pubmed.ncbi.nlm.nih.gov/PMC2754175 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwEB71ISEkVCivpoXWB4TEwTTOOrFzQhVsVYFaVW0PcIriR8Qe6labTaX--87ksctSQJx6jZ8Zj-3PnvE3AO9EbJV2UnFlveYyHcVce53zSpRJor1XqmXXPzpXJ9_1lzHR5IThLUwvwfojuVVhj9rFmmY33Ubv90bGfYGwQSLQRbiTy0yKT83ssuhuu4egGvSFzNPNJVm2LflD3vLhddsqrBNxHs6I9YOz0_Mf87VbqTYkJ9XPqYGFYfNem0sb2ZPrskaZVl0wjD-h1ftOl794jrWb2eHThxbDM9joYS876PR0E1Z8eA6PjnvD_gv42hoTmA_uqmONZVM_o_LTpubfhGbjcMPKmpWMfOFZFyWITQIbHCJZjfWioCb1S7g4HF98PuJ9mAduU53NuHCpU4hckspraaXNiIQwThyezCpnrZPOlW6U21zmZmRiZWRijC4NKpnxiEZewVq4Cn4LGKKxTMWVyuyokqXROtNGCy_JFonnqDSCD8OQFdcdmUcher7z32UZwe7SmM4LJETihxocwc4wyMUwXAUCJgR0aRJHsDdPxQlLVpgyeBRfQU5qUsl_5MhyJRDW6Qhedyqz6CyurgJPiBGoJWWaZyCy8OWUMPnZkoYnKpUIFSN4Tyq16PHf_n_7fzPuwOPWh6Z9n_kG1mbTxr-F1do1u_3sugOcmzg6 |
link.rule.ids | 230,315,782,786,887,27926,27933,27934,44981,45369 |
linkProvider | SAGE Publications |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwEB1BkQAJsS9hKT4gJA5GSerEzhFBUVmFoAc4RfES0UtATcv3M07SlLIJibMnjj0e22_s8RuAA89VXGjGKVdGUBa0XCqMiGjqJb4vjOG8YNfvPPDbR3HWtjQ5daqvSoP5sQ2rwhYVi3U9u-07cUQMDDEuIp2IhfbJ-gz-IUSDnjm5v3t4qpdhzovsmlae2g_Gd5Rf6pjYkxZekxzVk5Z5Lb4Dnl_jJz8EgRX70vnSP3q0DIsVGCUnpfWswJTJVmH2prpuX4PL4oifmEy_lFyupG8G9gyiP8zplSdIO3sjSU4SYiPUSZm7h_QyMgpTJDnWi33u5evQPW93Tzu0Sr5AVSDCAfV0oDniCT81gimmQksN6Poa_aVUK6WZ1oluRSpikWxJl0vmSykSiUMvDWKEDWhkL5nZAoIYKeRuykPVSlkihQiFFJ5h9oYQvZvAgaOR9uPXkmIj9ioW8s-6caA5MTz1B76l1kO7cmBnNF7xSPMxwhiEWYHvOrBfl-I0sncjSWZQfbENHWOc_SIRRujPe1w4sFmO_rixuOZ56Lc5wCfsohawFN6TJVnvuaDy9nnAEMA5cGitY9zin_q__VfBfZjrdG-u4-uL26sdmC-iXIoXlLvQGPSHZg-mcz1sVpPmHRceECM |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LTxsxEB4VkCIkRFueCxR8QJU4mKw33rX3wCGCRLRpEQIOcFqtHytyWaJswu9nvI-kIW1VqWc_ZI_H9jee8TcAp8zXQhouqNBWUh52fCqtjGnG0iCQ1gpRsutf34ubR3nVczQ5F81fmFqCxbkLq8IRlYe1290jk7VrH2ObIWrgiHMR7cQ8ct_W1ziPJe7Lte7d7f3T7CgWosyw6epT12Dup1zqY-Fe2hilBYooq3Jb_A58LsdQ_hIIVt5N_Y__OatPsFmDUtKttOgzfLD5FrR-1m73bfhePvUTm5uXitOVjO3EvUWMpwUdMEl6-StJC5ISF6lOqhw-ZJiTJlyRFNgvzntY7MBDv_dweU3rJAxUhzKaUGZCIxBXBJmVXHMdOYpAPzBoN2VGa8ONSU0n1jGPVUf5QvFAKZkqVAFlESvswmr-ktt9IIiVIuFnItKdjKdKykgqySx3nkK0ckIPzpoVSEYV1UbCajby97Lx4HhhiWYNAkexh_rlwWGzZkkj_QThDMKtMPA9OJmV4nZyPpI0tyi-xIWQccH_UiOK0a5nQnqwV2nAfLB49jG03zwQC7oxq-CovBdL8uFzSekdiJAjkPPgq9OQ-Yj_NP-Df614Aq3bq37y49vN4BDWy2CX8iPlEaxOxlP7BVYKMz2u980bDPcSoA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+endogenous+retrovirus-K18+Env+as+a+risk+factor+in+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Tai%2C+A+K&rft.au=O%27Reilly%2C+E+J&rft.au=Alroy%2C+KA&rft.au=Simon%2C+K+C&rft.date=2008-11-01&rft.issn=1352-4585&rft.volume=14&rft.issue=9&rft.spage=1175&rft.epage=1180&rft_id=info:doi/10.1177%2F1352458508094641&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-4585&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-4585&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-4585&client=summon |